Search:

Home Index Back issues Contact

 

Here is a convenient index of articles that have appeared in recent issues of the journal. The article titles are presented, with the keyword given first. Click on any title to find out more about the content.

 

Article title

Issue

 

Acute myeloid leukaemia, Novel therapeutic approaches in
Jonathan Kell MA (Cantab) MB BChir MRCPath MD Consultant Haematologist; Alan K Burnett MB MD FRCPath FRCP(Edin) Professor of Haematology, University of Wales College of Medicine, Cardiff
1.4
Acute promyelocytic leukaemia: The use of molecularly targeted therapy in acute promyelocytic leukaemia
David Grimwade PhD MRCP MRCPath Senior Lecturer (Honorary Consultant), Department of Medical and Molecular Genetics, King’s College London
3.2
Allogeneic transplant patients,The role of the nurse in the follow-up of
Nikki McKeag RGN Onc Cert BSc(Hons) MSc Clinical Nurse Specialist in Bone Marrow Transplantation, Southampton University Hospitals NHS Trust, Southampton
1.3
Anaemia: Transfusion and alternatives for cancer-related anaemia
Jonathan Wallis BA MBBS FRCP FRCPath Consultant Haematologist, Department of Haematology, Freeman Hospital, Newcastle-upon-Tyne
2.3
Aromatase inhibitors, Breast cancer: the changing face of
Roberto Alonzi BSc MBBS MRCP FRCR Specialist Registrar in Clinical Oncology; Andreas Makris MA MRCP FRCR MD Senior Lecturer and Consultant in Clinical Oncology, Mount Vernon Hospital, Middlesex
1.3

 

Bevacizumab: Bevacizumab saves the day
Robert Thomas FRCP MD FRCR Consultant Oncologist, Addenbrooke’s and Bedford Hospitals; Sanjay Raj MRCP Specialist Registrar, Oncology, Addenbrooke’s Hospital; Ahmed Eldin FRCS Consultant Surgeon, Bedford Hospital, Cambridge University NHS Foundation Trust
2.2
Breast cancer: Adjuvant breast cancer drugs – blockbusters or bankrupters?
Robert Thomas FRCP MD FRCR Consultant Oncologist, Addenbrooke’s and Bedford Hospitals, Cambridge University NHS Foundation Trust; Brendan O’Sullivan MPharm Lead Pharmacist, Oncology Department, Addenbrooke’s Hospital, Cambridge University NHS Foundation Trust; John Glen BSc MSc PGCE Director of Economics, Cranfield University; Michael Callam MBChB FRCS ChM Consultant Surgeon, Bedford Hospital NHS Trust
2.3
Breast cancer: Cardiac issues in adjuvant breast cancer treatment
Yasser Haba MRCP Specialist Registrar, Oncology Department, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust; Catherine Jephcott BMBCh MA MRCP FRCR Consultant Oncologist, Peterborough and Stamford Hospitals NHS Foundation Trust
3.1

 

Cancer patients, Informing
Monica Morris RGN Head of Patient Services Development, International Myeloma Foundation (UK), Edinburgh
1.2
Cetuximab: Cetuximab – a new team player
Yasser Haba MRCP Specialist Registrar, Oncology Department, Addenbrooke’s Hospital, Cambridge; Myrddin Rees MS FRCS FRCSEd Consultant Surgeon, North Hampshire Hospital, Basingstoke; David Skipper MBBS MS FRCS Consultant Surgeon, Bedford Hospital; Robert Thomas FRCP MD FRCR Consultant Oncologist, Addenbrooke’s and Bedford Hospitals, Cambridge University NHS Foundation Trust
2.3
Chemotherapy for bladder cancer, Neoadjuvant
Tevita F’Aho MB ChB FRACS(Urol) Locum Consultant Urologist; David E Neal FMedSci MS FRCS Professor of Surgical Oncology/Honorary Consultant Urologist, University of Cambridge, Department of Oncology, Addenbrooke’s NHS Trust, Cambridge
1.4
Chronic lymphocytic leukaemia, Prognostic factors in
Geoffrey P Summerfield DM FRCP FRCPath Consultant Haematologist and Senior Lecturer in Haematology, Queen Elizabeth Hospital, Sheriff Hill, Gateshead
1.3
Chronic myeloid leukaemia, The use of imatinib in
Richard E Clark MA MD FRCP FRCPath Professor of Haematology and Consultant Haematologist, Lihui Wang MD Clinical Scientist in Haematology, Department of Haematology, Royal Liverpool University Hospital, Liverpool
1.3
Clinical nurse specialist, Specialism in MDTs: the role of the
Tricia Feber MSc RGN Macmillan Clinical Nurse Specialist, Head and Neck Cancer, Leeds Teaching Hospitals, Leeds; Chrissie Lane MA RGN Lead Cancer Network Nurse, Yorkshire Cancer Network, Leeds: Julie Hoole BSc Hons RGN DN Macmillan Head and Neck Cancer Nurse Specialist, Mid Yorkshire NHS Trust, Wakefield; Sarah Cost MA RGN DN ONC Macmillan Head and Neck Cancer Nurse Specialist, Bradford Teaching Hospitals NHS Foundation Trust, Bradford
1.4
Comment: Latest developments
Graham H Jackson, Editor
1.2
Comment: Making a fresh start
Graham H Jackson, Editor
2.1
Comment: New title for a new era
Graham H Jackson, Editor
1.1
Comment: NICE’s opinion not so nice for myeloma patients
Graham H Jackson, Editor
3.2
Comment: So much to do, so little time
Graham H Jackson, Editor
3.1
Complementary medicine: Complementary and alternative medicine evidence online for cancer
Janet Richardson BSc PhD RN CPsychol PGCE RNT Reader in Nursing and Health Studies, Faculty of Health and Social Work, University of Plymouth; Karen Pilkington BPharm(Hons) DipInfSci MSc PCME MRPharmS Project Manager/Senior Research Fellow, School of Integrated Health, University of Westminster, London; Robert Thomas FRCP MD FRCR Consultant Oncologist, Addenbrooke’s and Bedford Hospitals, Cambridge University NHS Foundation Trust
2.2
Compliance or concordance: what’s in a word?
Jean Mossman BSc Healthcare Consultant, Kilmacolm, Renfrewshire
2.1
Consent, The changing face of informed patient
Robert Thomas FRCP MD FRCR Consultant Clinical Oncologist, Addenbrooke’s and Bedford Cambridge University NHS Trust, Cambridge
1.1
Consultation: What makes a good consultation?
Steve Johnson FRCP FRCPath Consultant Haematologist, Taunton and Somerset Hospital
3.1
Cost–benefit analysis in cancer imaging
Ashley Shaw MRCP FRCP Consultant Radiologist; Adrian Dixon MD FRCR FRCP FRCS FMedSci Professor of Radiology, Department of Radiology, Addenbrooke’s Hospital, Cambridge and the University Hospitals NHS Foundation Trust, Cambridge
1.4

 

Dietetics: Diet, salicylates and their effect on prostate cancer
Robert Thomas FRCP MD FRCR Consultant Oncologist, Addenbrooke’s and Bedford Hospitals, Cambridge University NHS Trust; Cathryn Woodward MRCP FRCR
3.1
Dietetics: Low microbial diets in immunocompromised patients
Wendy Rees BSc SRD Senior Dietitian, Gloucestershire Royal Hospital, Gloucester
2.2

 

Eccrine porocarcinoma
Carolyn L Datta SMBChB MRCP Specialist Registrar in Palliative Medicine, The Ayrshire Hospice, Ayr; Barry J A Laird MBChB MRCGP Specialist Registrar in Palliative Medicine, Beatson Oncology Centre, Western Infirmary, Glasgow
3.2
Erythropoietin management
Robert Thomas FRCR MD FRCP Consultant Clinical Oncologist, Addenbrooke’s and Bedford Hospitals, Cambridge University NHS Foundation Trust; Daniel Epurescu MRCP FRCR Consultant Oncologist, Norfolk and Norwich NHS Trust; Madeleine Williams BA Research Manager, Bedford Hospital NHS Trust; Karen McAdam MD FRCP Consultant Oncologist, Addenbrooke’s Hospital, Cambridge
1.3

 

Funding: Are the newspapers the only ones interested in debate?
Graham H Jackson, Editor
2.4
Funding: Funding for cancer drugs – time for clearer thinking
Graham H Jackson, Editor
2.2
Funding: Funding for cancer in the UK
Joanne Rule Chief Executive, Cancerbackup
3.1

 

Hairy cell leukaemia, A review of treatment options in
PJ Hayden MB BA MRCP (I) MRCPath Lecturer in Haematology; SR McCann MB FRCP (I) FRCP (Edin) FRCPath Professor of Haematology, University of Dublin, Trinity College; and St James’s Hospital, Dublin
1.2

 

Imaging techniques in cancer management, New
Cynthia Gupte BSc BMBCh MRCS DLO Specialist Registrar, Hammersmith Hospital, London; Anwar R Padhani FRCP FRCR Consultant Radiologist, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex
1.2

 

Mantle cell lymphoma: The clinical management of mantle cell lymphoma
Simon Rule MPhil FRCP FRCPA Consultant Haematologist and Honorary Senior Lecturer, Derriford Hospital, Plymouth
2.2
Mesothelioma: Benefits and compensation for mesothelioma patients
Liz Darlison RN BSc FETC Nurse Consultant, The National Macmillan Mesothelioma Resource Centre, Leicester; Anthony Whitston MA MIOSH Asbestos Project Worker, Greater Manchester Asbestos Victims Support Group
2.3
Mesothelioma: Intestinal obstruction and mesothelioma of the pleura
Cathryn Woodward MRCP FRCR Consultant Oncologist, Addenbrooke’s Hospital, Cambridge; Paul Tisi MS FRCR Consultant Surgeon, Bedford Hospital; David Gilligan BSc FRCP(Edin) FRCR Consultant Oncologist, Addenbrooke’s Hospital, Cambridge
3.1
Mesothelioma: Pemetrexed in the management of malignant pleural mesothelioma
Debashis Biswas BSc MRCP Specialist Registrar in Clinical Oncology, Addenbrooke’s Hospital, Cambridge; David Gilligan BSc FRCP FRCR Consultant Oncologist, Thoracic Oncology Unit Addenbrooke’s and Papworth Hospitals, Cambridge
2.1
Monoclonal antibodies: Monoclonal antibodies in colorectal cancer
Hugo Ford MD MRCP Consultant Medical Oncologist, Addenbrooke’s Hospital, Cambridge
2.4
Multiple myeloma: Bortezomib combination therapy for multiple myeloma
Rakesh Popat MRCP Clinical Research Fellow; Heather Oakervee MRCPath Senior Lecturer and Honorary Consultant; Jamie Cavenagh MD FRCP FRCPath Senior Lecturer and Honorary Consultant, Department of Haematology, St Bartholomew’s Hospital, London
2.2
Multiple myeloma: Diagnosis and management of multiple myeloma
Alastair G Smith BSc MBChB FRCP (Glasgow & London) FRCPath Consultant Haematologist and Honorary Clinical Senior Lecturer, Southampton General Hospital, Southampton University Hospitals NHS Trust
3.2
Multiple myeloma: Multiple myeloma and renal failure
Judith Behrens Dip Obs RCOG FRCP FRCPath Consultant Haematologist, St Helier Hospital, Surrey; Graham H Jackson MA MBBS FRCP FRCPath MD Clinical Director of Haematology, Newcastle-upon-Tyne Hospitals NHS Trust
2.4
Myeloma, A guide to the new therapies in multiple
Graham H Jackson MA(Cantab) MBBS(Hons) FRCP FRCPath MD Clinical Director of Haematology, The Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle-upon-Tyne
1.1
Myeloma: The sequencing of treatments for multiple myeloma
Gareth Morgan PhD FRCP FRCPath Consultant in Haematology; Faith Davies MBBCh MD MRCP MRCPath Department of Health Clinician Scientist, Royal Marsden Hospital, Sutton
2.3

 

Nausea and vomiting: Palliation of cancer-related nausea and vomiting
Kathryn Mannix MB BS FRCP Consultant in Palliative Medicine, Royal Victoria Infirmary and Marie Curie Hospice, Newcastle-upon-Tyne
2.4
NICE guidance on supportive and palliative care, The
Robert Thomas FRCP MD FRCR Consultant Clinical Oncologist, Addenbrooke’s and Bedford Hospitals, Cambridge University NHS Foundation Trust, Alison Richardson RN PhD Chair in Cancer, Palliative Nursing Care, Florence Nightingale School of Nursing and Midwifery, King’s College London
1.3
NICE: The managed introduction of non-NICE cancer drugs
Steve Williamson BPharm, MRPharmS Lead Pharmacist, Cancer Services, Northumbria Healthcare NHS Trust; Lead Pharmacist, Northern Cancer Network
2.3
NICE: What about rarer diseases and the drugs NICE doesn’t look at?
Graham H Jackson, Editor
2.3
Non-Hodgkin’s lymphoma: Management of relapsed histologically aggressive non-Hodgkin’s lymphoma
Catherine Burton MB BChir MA MRCP Clinical Research Fellow; David Linch MB BChir FRCP FRCPath F Med Sci Professor of Haematology, Department of Haematology, University College London, London
2.1
Non-Hodgkin's lymphoma: Treating histologically aggressive non-Hodgkin’s lymphoma
Catherine Burton MB BChir MA MRCP Clinical Research Fellow; David Linch MB BChir FRCP FRCPath FMedSci Professor of Haematology, Department of Haematology, University College London
2.2
Nursing: Agenda for Change in nursing – grading of specialist nurses
Jackie Green RGN OncDip MSc Nurse Consultant and Lead Cancer Nurse, Advanced Clinical Practice, Mayday Healthcare NHS Trust, Croydon
2.1
Nutrition: The role of assisted nutrition
Orla Hynes BSc Oncology Dietitian, Addenbrooke’s Hospital, Cambridge
2.4

 

Oesophagogastric cancer: Recognising high-risk groups for oesophagogastric cancer
Rebecca Fitzgerald MA(Cantab) MBBChir MD FRCP Programme Leader, Cancer Cell Unit, Hutchison Medical Research Council Research Centre; Honorary Consultant Gastroenterologist, Addenbrooke’s Hospital, Cambridge
3.2

 

Pain relief: Non-opioid pain relief
Marcia Schofield MSc MA MB BChir Clinical Research Assistant; Rajesh Munglani FRCA Consultant in Pain Management, West Suffolk Hospital, Bury St Edmunds
3.2
Pain?, NSAIDs: are they effective in treating cancer
Abdullah Alkhenizan, Consultant, Department of Family Medicine and Polyclinic, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; Larry Librach, Director, The Temmy Latner Center for Palliative Care, Mount Sinai Hospital, Toronto, W Gifford-Jones Professor of Pain Control and Palliative Care, University of Toronto; Joseph Beyene, Assistant Professor, Division of Neonatology, University of Toronto, Canada
1.1
PET saves man
Robert Thomas FRCP MD FRCR Consultant Clinical Oncologist, Primrose Oncology Unit, Bedford Hospital NHS Trust, Bedford; Sally Old BSc MRCP FRCR Consultant Clinical Oncologist, Addenbrooke’s Hospital NHS Trust, Cambridge
1.1
PET scanning: The role of PET scanning in lymphoma assessment
Jamshed B Bomanji MBBS MSc PhD Consultant Physician/Honorary Senior Lecturer; Peter J Ell MD MSc PhD FRCP FRCR Professor of Nuclear Medicine, Institute of Nuclear Medicine, University College Hospital, London
2.1
Prostate brachytherapy, Why the prognosis is good for
Brendan Carey MB BCh BAO(NUI) FRCR Consultant Radiologist, Cookridge Hospital, Leeds
1.1
Proteosome inhibition as cancer therapy
Faith E Davies MB BCh MRCP MD MRCPath Department of Health Clinician Scientist, Section of Haemato-Oncology, The Institute of Cancer Research, London
1.2

 

Radiotherapy for bladder cancer: improving outcomes
Stephen Mangar MRCP MSc FRCR Research Fellow; Vincent Khoo MD FRACR FRCR Consultant in Clinical Oncology, Academic Department of Radiotherapy, Royal Marsden Hospital, London
1.4
Rituximab: Rituximab as maintenance therapy in follicular NHL
Graham H Jackson MA MBBS FRCP FRCPath MD Clinical Director of Haematology, Newcastle-upon-Tyne Hospitals NHS Trust
3.1

 

Splenic rupture: Splenic rupture following high-dose melphalan for myeloma
Yogesh Upadhye MBBS MRCP Specialist Registrar, Ninewells Hospital, Dundee
2.4
Supplementary prescribing: Supplementary prescribing
Carl Booth MPhil MRPharmS Lead Oncology Pharmacist and Joint Non-medical Prescribing Lead, Airedale NHS Trust
2.4
Supportive care
Graham H Jackson, Editor
1.4

 

Targeted care
Graham H Jackson, Editor
1.3
Thrombosis and cancer
Kate Hodgson MBBS BMedSci MRCP Specialist Registrar; John Hanley MD FRCP MRCPath Consultant Haematologist, Royal Victoria Infirmary, Newcastle-upon-Tyne
1.2
Transfusion and cancer: current concerns, Blood
Angus W Wells MRCP(UK) MRCPath Consultant in Transfusion Medicine; Hazel N Tinegate FRCP FRCPath Consultant in Transfusion Medicine, National Blood Service, Newcastle-upon-Tyne
1.4
Tumour-associated macrophages on tumour growth and their role in gene therapy, Effects of
Craig Murdoch PhD Research Fellow; Claire E Lewis BSc MA DPhil Professor of Molecular and Cellular Pathology, Division of Genomic Medicine, University of Sheffield Medical School, Sheffield
1.1

 

Velcade: Trial news – Velcade
Graham H Jackson MA(Cantab) MBBS(Hons) FRCP FRCPath MD Clinical Director of Haematology, Newcastle-upon-Tyne Hospitals NHS Trust
2.1

 


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title British Journal of Cancer Management is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk